Heparin-Induced Thrombocytopenia - Retrospective Analysis of Data on Incidence and Outcomes Study

NCT01178333 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 668

Last updated 2015-05-22

Study results available
· View outcomes & findings →

Summary

HIT-RADIO is a study of patients who had a positive heparin PF-4 antibody test between 1/21/2008 and 9/25/2008 at selected hospitals. The study will collect and analyse information that is already in the patients' medical records. Information about laboratory values (such as platelet counts), treatments (such as medications), and outcomes (such as blood clots, amputation, and death) will be included.

Conditions

  • Heparin Induced Thrombocytopenia

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH
  • Carelon Research

    lead OTHER

Principal Investigators

  • Susan F Assmann, PhD · Carelon Research

  • David Kuter, MD · Massachusetts General Hospital

  • Eliot Williams, MD PHD · University of Wisconsin, Madison

  • Kenneth Friedman, MD · Versiti

  • Ronald Go, MD · Gunderson Clinic

  • Keith McCrae, MD · The Cleveland Clinic

  • Ellis Neufeld, MD PHD · Boston Children's Hospital

  • Lynne Uhl, MD · Beth Israel Deaconess Medical Center

  • Judith Lin, MD · Brigham and Women's Hospital

  • James Bussel, MD · Cornell University

  • Thomas Ortel, MD PHD · Duke University

  • Jodi Segal, MD MPH · Johns Hopkins University

  • Barbara Konkle, MD · Bloodworks

  • Cindy Leissinger, MD · Tulane University

  • Thomas Raife, MD · University of Iowa

  • Ann Zimrin, MD · University of Maryland Greenebaum Cancer Center

  • Jeffrey McCullough, MD · University of Minnesota

  • Nigel Key, MD · University of North Carolina, Chapel Hill

  • Bruce Sachais, MD PHD · University of Pennsylvania

  • Joseph Kiss, MD · University of Pittsburgh Institute for Transfusion Medicine

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01178333 on ClinicalTrials.gov